Literature DB >> 33764422

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017.

Micah B Aaron1, Anna D Sinaiko2.   

Abstract

Entities:  

Year:  2021        PMID： 33764422      PMCID： PMC7994951          DOI： 10.1001/jamanetworkopen.2021.3252

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  4 in total

1.  Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019.

Authors:  Stacie B Dusetzina; Haiden A Huskamp; Nancy L Keating
Journal:  JAMA       Date:  2019-05-28       Impact factor: 56.272

2.  Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.

Authors:  Inmaculada Hernandez; Alvaro San-Juan-Rodriguez; Chester B Good; Walid F Gellad
Journal:  JAMA       Date:  2020-03-03       Impact factor: 56.272

Review 3.  Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

Authors:  Dana P Goldman; Geoffrey F Joyce; Yuhui Zheng
Journal:  JAMA       Date:  2007-07-04       Impact factor: 56.272

4.  Affording Medicines for Today's Patients and Sustaining Innovation for Tomorrow.

Authors:  Kenneth C Frazier
Journal:  JAMA       Date:  2020-03-03       Impact factor: 56.272
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.